You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

K-Ras

Showing 1 - 25 of 2,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Metastatic Colorectal Cancer Trial in France (Nexavar (Sorafenib) and irinotecan (Campto))

Completed
  • Metastatic Colorectal Cancer
  • Nexavar (Sorafenib) and irinotecan (Campto)
  • Lille, France
  • +4 more
Jun 17, 2021

Colorectal Cancer Trial in Nanjing, Beijing (Nimotuzumab, Irinotecan)

Completed
  • Colorectal Cancer
  • Nanjing, Jiangsu, China
  • +1 more
Mar 3, 2022

Metastatic Colorectal Cancer and the Role of K-Ras

Active, not recruiting
  • Metastatic Colorectal Cancer
    • Benevento, Italy
    • +3 more
    Mar 3, 2021

    Pancreatic Adenocarcinoma, Lung Cancer Trial in Truro (Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF

    Unknown status
    • Pancreatic Adenocarcinoma
    • Lung Cancer
    • Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples
    • Truro, Cornwall, United Kingdom
      Royal Cornwall Hospital
    Feb 26, 2021

    Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

    Completed
    • Infiltrating Urothelial Carcinoma
    • KRAS Gene Mutation
    • Bordeaux, France
    • +16 more
    Mar 4, 2021

    Metastatic Colorectal Cancer Trial in United States (cetuximab, 5-FU, oxaliplatin)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • cetuximab
    • +3 more
    • Loma Linda, California
    • +22 more
    Oct 4, 2021

    NSCLC Metastatic Trial in Dijon (CTC)

    Terminated
    • Non-small Cell Lung Cancer Metastatic
    • CTC
    • Dijon, France
      Centre Georges François Leclerc
    Jan 24, 2020

    Colon Cancer Stage III Trial in Mansoura (k ras, Panitumumab)

    Completed
    • Colon Cancer Stage III
    • Mansoura, Ad Daqahliyah, Egypt
      Mansoura University Oncology Center
    Apr 8, 2020

    Colorectal Cancer Trial in Cyprus, United Kingdom (biological, drug, other)

    Completed
    • Colorectal Cancer
    • cetuximab
    • +6 more
    • Nicosia, Cyprus
    • +24 more
    Sep 15, 2021

    Stroke, Old Age Trial in Boston (Subject-specific optimized RAS, Active walking)

    Recruiting
    • Stroke
    • Old Age
    • Subject-specific optimized RAS
    • Active walking
    • Boston, Massachusetts
      Boston University Neuromotor Recovery Laboratory
    Oct 13, 2023

    Acoustic Stimulation, Parkinson Disease, Electroencephalography Trial (Upper-limb training involving RAS, Upper-limb training

    Not yet recruiting
    • Acoustic Stimulation
    • +2 more
    • Upper-limb training involving RAS
    • Upper-limb training without the aid of RAS
    • (no location specified)
    Mar 13, 2023

    Parkinson Disease Trial (Rhythmic Auditory Stimulation (RAS))

    Not yet recruiting
    • Parkinson Disease
    • Rhythmic Auditory Stimulation (RAS)
    • (no location specified)
    Mar 9, 2023

    ANGIOPREDICT. ICORG 12-16, V3

    Completed
    • Advanced Colorectal Cancer
    • Biomarker analysis
    • Speyer, Rhineland-Palatinate, Germany
    • +16 more
    Feb 25, 2020

    Metastatic Colorectal Cancer Trial in Vancouver, Ottawa, Toronto (BKM120, Panitumumab)

    Completed
    • Metastatic Colorectal Cancer
    • Vancouver, British Columbia, Canada
    • +2 more
    Apr 6, 2020

    Acoustic Stimulation, Parkinson Disease, Movement, Abnormal Trial (Upper-limb movement training with the aid of RAS, Upper-limb

    Not yet recruiting
    • Acoustic Stimulation
    • +4 more
    • Upper-limb movement training with the aid of RAS
    • Upper-limb movement training without the aid of RAS
    • (no location specified)
    Dec 12, 2022

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Metastatic Colorectal Cancer Trial in France (Folfirinox + regorrafenib)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Folfirinox + regorrafenib
    • Nice, Alpes-Maritimes, France
    • +3 more
    Jan 16, 2023

    Cerebral Activation by fNIRS During Gait With Different Rhythmic

    Completed
    • Healthy
    • walking 25 m in 4 different conditions
    • Orléans, France
      CHR Orléans
    Mar 29, 2023

    Colorectal Cancer Trial in Canada (cetuximab, brivanib alaninate)

    Completed
    • Colorectal Cancer
    • cetuximab
    • brivanib alaninate
    • Calgary, Alberta, Canada
    • +36 more
    Apr 2, 2020

    K-RAS and EGFR in Lung Cancer

    Completed
    • Non Small Cell Lung Cancer
      • Néo Fáliro, Athens, Greece
        Oncology Unit, Metropolitan Hospital
      May 14, 2019

      Colorectal Cancer Trial in Germany (Cetuximab, Bevacizumab, Irinotecan)

      Unknown status
      • Colorectal Cancer
      • Aachen, Germany
      • +14 more
      Sep 9, 2019

      Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

      Not yet recruiting
      • Overweight and Obesity
      • 24-hour ambulatory blood pressure
      • Liberal salt diet
      • (no location specified)
      Oct 4, 2023

      Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)

      Completed
      • Covid-19
      • Discontinuation of ACEi/ARB
      • Continuation of ACEi/ARB
      • Hellerup, Capital Region Of Denmark, Denmark
      • +1 more
      Jan 17, 2023

      Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))

      Completed
      Has Results
      • Severe Hypertriglyceridemia
      • Birmingham, Alabama
      • +219 more
      Nov 9, 2022